Affiliation:
1. Consultant Pharmacist, Geriatrics and Palliative Care, Australia
Abstract
Recent research in new drug treatments for dementia such as anti-amyloid therapies have certainly piqued interest in the future possibilities for dementia pharmacotherapy. However, as with many
medicines, the drugs have side effects, are expensive, and the evidence is still evolving. Furthermore, the first principles in any disease state management are prevention and non-pharmacological management.
In this editorial, I invite you to look at dementia management based on three pillars. These, in my view, are all equally important. They are preventive and social medicine, medicine (prescribing), and
deprescribing.
Publisher
American Society of Consultant Pharmacists
Reference17 articles.
1. They are here: anti-amyloid therapies to treat dementia;Sr Care Pharm.,2024
2. Association of loneliness with 10-year dementia risk and early markers of vulnerability for neurocognitive decline;Neurology.,2022
3. Evaluation of dementia-friendly initiatives, small-scale homelike residential care, and dementia village models: a scoping review;JAMDA,2023
4. Creating a meaningful everyday life: perceptions of relatives of people with dementia and healthcare professionals in the context of a Danish dementia village;Dementia (London),2020